SOBI:STO
Swedish Orphan Biovitrum AB (publ)
SEK 498.20
arrow_upward
+0.93%(+4.60) 1D
11-р сарын 6, 17:29:36 (GMT+1) · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SOBI...
Open
SEK 483.00
High
SEK 498.20
Low
SEK 479.00
Mkt. cap
178.17Т
Avg. vol.
341.57 мян
Volume
563.09 мян
P/E ratio
26.46
52-wk high
SEK 498.20
52-wk low
SEK 314.40
EPS
SEK 18.83
Shares outstanding
357.64 сая
No. of employees
2 мян
Open
SEK 483.00
High
SEK 498.20
Low
SEK 479.00
Mkt. cap
178.17Т
Avg. vol.
341.57 мян
Volume
563.09 мян
P/E ratio
26.46
52-wk high
SEK 498.20
52-wk low
SEK 314.40
EPS
SEK 18.83
Shares outstanding
357.64 сая
No. of employees
2 мян
News stories
From web sources and news partners
TradingView
·
1 цагийн өмнө
QQQ Vs. TQQQ: 3X Nasdaq ETFs Compounding Trap Is Costing Investors Big
Investor's Business Daily
·
13 минутын өмнө
Nasdaq Crashes Through This Key Chart Level; What Should Smart Traders Do Now?
Bloomberg.com
·
2 цагийн өмнө
Anatomy of a Selloff: Sudden Chain Reaction Rattles Wall Street
Seeking Alpha
·
1 цагийн өмнө
Why The Fed Hikes In December: Strong Jobs, Low Layoffs (SP500)
Profile
Sobi - Swedish Orphan Biovitrum AB is an international biopharmaceutical company focused on rare diseases. The company develops, commercializes, and delivers therapies in the fields of haematology, immunology and specialty care. Headquartered in Stockholm, Sweden, with major hubs in Basel, Switzerland, and Waltham, USA.
Sobi has a global presence in approximately 30 countries and provides medicines to patients in many more around world. The company develops treatments for patients living with complex and chronic rare conditions and maintains a pipeline of development and lifecycle management programs focused on advancing innovative therapies for diseases with significant unmet medical needs. Wikipedia
About Swedish Orphan Biovitrum AB (publ)